Translational Research
Volume 155, Issue 6 , Pages 305-314 , June 2010

Antiproliferative effect of Toona sinensis leaf extract on non–small-cell lung cancer

  • Chih-Jen Yang

      Affiliations

    • Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
    • ,
  • Yu-Jung Huang

      Affiliations

    • Department of Physiology, Kaohsiung Medical University, Kaohsiung, Taiwan
    • ,
  • Cheng-Yuan Wang

      Affiliations

    • Department of Physiology, Kaohsiung Medical University, Kaohsiung, Taiwan
    • ,
  • Pei-Hui Wang

      Affiliations

    • Department of Physiology, Kaohsiung Medical University, Kaohsiung, Taiwan
    • ,
  • Hseng-Kuang Hsu

      Affiliations

    • Department of Physiology, Kaohsiung Medical University, Kaohsiung, Taiwan
    • ,
  • May-Jywan Tsai

      Affiliations

    • Neural Regeneration Laboratory, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan
    • ,
  • Yu-Chu Chen

      Affiliations

    • Kaohsiung District Agricultural Research and Extension Station Council of Agriculture, Executive Yuan, Pingtung County, Taiwan
    • ,
  • V. Bharath Kumar

      Affiliations

    • Institute of Biotechnology, National Dong Hwa University, Hualien, Taiwan
    • ,
  • Ming-Shyan Huang

      Affiliations

    • Department of Physiology, Kaohsiung Medical University, Kaohsiung, Taiwan
    • ,
  • Ching-Feng Weng

      Affiliations

    • Institute of Biotechnology, National Dong Hwa University, Hualien, Taiwan
    • Corresponding Author InformationReprint requests: Ching-Feng Weng, Institute of Biotechnology, National Dong Hwa University, D209, Hualien 974, Taiwan

Received 14 September 2009 ,Revised 12 February 2010 ,Accepted 16 March 2010.

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2006;56(106):130
  2. AbouEl Hassan MA, Braam SR, Kruyt FA. Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells. Cancer Gene Ther. 2006;13:1105–1114
  3. Losiewicz MD, Carlson BA, Kaur G, Sausville EA, Worland PJ. Potent inhibition of cdc2 kinase activity by the flavonoid L86-8275. Biochem Biophys Biophys Res Commun. 1994;201:589–595
  4. Carlson BA, Dubay MM, Sausville EA, Brizuela L, Worland PJ. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase CDC2 and CDK4 in human breast carcinoma cells. Cancer Res. 1996;56:2973–2978
  5. Carlson BA, Pearlstein RA, Naik RG, Sedlacek HH, Sausville EA, Worland PJ. Inhibition of CDK2, CDK4 and CDK7 by flavopiridol and structural analogs. Proc Am Assoc Cancer Res. 1996;34:424
  6. Dumant JA. HMR Report No. B/98/0189/R, B/98/0188/R, 8/98/0187/R. HMR Oncology; 1996.
  7. Seynaeve CM, Stetler-Stevenson M, Sebers S, Kaur G, Sausville EA, Worland PJ. Cell cycle arrest and growth inhibition by the protein kinase antagonist UCN-01 inhuman breast carcinoma cells. Cancer Res. 1993;53:2081–2086
  8. Akinaga S, Nomura K, Gomi K, Okabe M. Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoind carcinoma, A431 cells. Cancer Chemother Pharmacol. 1994;33:273–280
  9. Kawakami K, Futami H, Takahara J, Yamaguchi K. UCN-01, 7 hydroxylstaurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. Biochem Biophys Res Commun. 1996;219:778–783
  10. Wille JJ, Scott RE. Topography of the predifferentiation GD growth arrest state relative to other growth arrest states in the G1-phase of the cell cycle. J Cell Physiol. 1982;112:115–122
  11. Carney DN. Lung cancer-time to move on from chemotherapy. New Engl J Med. 2002;2:126–128
  12. Chang HC, Hung WC, Huang MS, Hsu HK. Extract from the leaves of Toona sinensis roemor exerts potent antiproliferative effect on human lung cancer cells. Am J Chin Med. 2002;30:307–314
  13. Chang HL, Hsu HK, Su JH, et al. The fractionated Toona sinensis leaf extract induces apoptosis of human ovarian cancer cells and inhibits tumor growth in a murine xenograft model. Gynecol Oncol. 2006;102:309–314
  14. Yang HL, Chang WH, Chia YC, et al. Toona sinensis extracts induces apoptosis via reactive oxygen species in human premyelocytic leukemia cells. Food Chem Toxicol. 2006;44:1978–1988
  15. Yang CJ, Huang YJ, Wang CY, et al. Anti-proliferative and anti-tumorgenic activity of Toona sinensis leaf extracts in lung adenocarcinoma. J Med Food. 2010;155:305–314
  16. Wang PH, Tsai MJ, Hsu CY, Wang CY, Hsu HK, Weng CF. Toona sinensis Roem (Meliaceae) leaf extract alleviates hyperglycemia via altering adipose glucose transporter 4. Food Chem Toxicol. 2008;46:2554–2560
  17. Yang CJ, Wang CS, Hung JY, et al. Pyrogallol induces G2-M arrest in human lung cancer cells and inhibits tumor growth in an animal model. Lung Cancer. 2009;66:162–168
  18. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol. 2002;64:681–708
  19. Cho EJ, Yokozawa T, Rhyu DY, Kim HY, Shibahara N, Park JC. The inhibitory effects of 12 medicinal plants and their component compounds on lipid peroxidation. Am J Chin Med. 2003;31:907–917
  20. Gali HU, Perchellet EM, Klish DS, Johnson JM, Perchellet JP. Antitumor-promoting activities of hydrolyzable tannins in mouse skin. Carcinogenesis. 1992;13:715–718
  21. Inoue M, Sakaguchi N, Isuzugawa K, Tani H, Ogihara Y. Role of reactive oxygen species in gallic acid-induced apoptosis. Biol Pharm Bull. 2000;23:1153–1157
  22. Bailey AE, Asplund RO, Ali MS. Isolation of methyl gallate as the antitumor principle of Acer saccharinum. J Nat Prod. 1986;49:1149–1150
  23. Zhang H, Wang X, Chen F, Androulakis XM, Wargovich MJ. Anticancer activity of limonoid from Khaya senegalensis. Phytother Res. 2007;21:731–734
  24. Valcic S, Timmermann BN, Alberts DS, et al. Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs. 1996;7:461–468
  25. Buolamwini JK. Cell cycle molecular targets in novel anticancer drug discovery. Curr. Pharm Des. 2000;6:379–392
  26. Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther. 2002;1:226–231
  27. Zhang YJ, Jiang W, Chen CJ, et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem Biophys Res Commun. 1993;196:1010–1016
  28. Tashiro E, Tsuchiya A, Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 2007;98:629–635
  29. K Ayed A, Adesina A. Prognostic significance of cyclin D1 expression in resected stage I, II non-small cell lung cancer in Arabs. Interact Cardiovasc Thorac Surg. 2006;5:47–51
  30. Tsuruo T, Nait M, Tomida A, Fujita N, Mashima T, Sakamoto H, et al. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci. 2003;94:15–21
  31. Otsuki Y, Li Z, Shibata MA. Apoptotic detection methods — from morphology to gene. Prog Histochem Cytochem. 2003;38:275–339
  32. Boulares AH, Yakovlev AG, Ivanova V, et al. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem. 1999;274:22932–22940
  33. D'Amours D, Sallmann FR, Dixit VM, Poirier GG. Gain-of function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci. 2001;114:3771–3778

PII: S1931-5244(10)00056-3

doi: 10.1016/j.trsl.2010.03.002

Translational Research
Volume 155, Issue 6 , Pages 305-314 , June 2010

Article Tools

* Image Usage & Resolution